Cell Division: Sibling cell size matters
Cell division is a highly regulated and tightly choreographed process. It ensures that the DNA, organelles and other components in a cell are correctly distributed between the two "sibling" cells that are produced during the cell division process. In most cases, the dividing cell ensures that the sibling cells are near identical in size. However, many types of cells, including baker’s yeast and cells in animal ovaries, produce sibling cells of different sizes. How and why dividing cells regulate the sizes of the sibling cells are unresolved questions in cell biology (Roubinet and Cabernard, 2014). Now, in eLife, Cuie Chen, Mayu Inaba, Zsolt Venkei and Yukiko Yamashita of the University of Michigan report a new mechanism that dividing cells use to ensure that both sibling cells are equal in size (Chen et al., 2016).
In animal and other eukaryotic cells, DNA is packaged into structures called chromosomes. During cell division, the chromosomes in a cell are divided into two groups by a structure called the spindle apparatus. In animal cells two organelles called centrosomes help to build the spindle apparatus (Nigg and Raff, 2009). It is important that the spindle apparatus is assembled correctly because asymmetric spindles could exert uneven spindle forces and may result in the sibling cells having incorrect numbers of chromosomes.
In the testes of male fruit flies, germline stem cells divide to produce one new germline stem cell and one gonialblast (which will go on to produce sperm cells) that are equal in size. Chen et al. found that the centrosomes of germline stem cells contain high levels of a motor protein called Klp10A. Decreasing the amount of Klp10A in these cells causes one of the centrosomes – presumably the older "mother" centrosome – to become much longer than normal. This, in turn, leads to the formation of asymmetric spindles and results in a new germline stem cell that is significantly larger than the gonialblast (Figure 1A,B). Despite the importance of centrosome activity for chromosome segregation, all of the chromosomes (except for the small fourth chromosome) segregate normally in Klp10A depleted germline stem cells.
This imbalance in centrosome activity seems to be specific to male germline stem cells since Klp10A depleted cells that are destined to become sperm do not show this behavior. A possible explanation is that male germline stem cells – like other stem cells – segregate their centrosomes asymmetrically during cell division with the new stem cell always retaining the mother centrosome. It is also possible that this specificity is due to the fact that germline stem cells are attached to hub cells, which provide a niche environment for the stem cells.
Why do germline stem cells need to form sibling cells of equal size? Chen et al. addressed this question by using live cell imaging to follow the fates of sibling cells in Klp10A depleted testes. These experiments revealed that the smaller gonialblasts often die. This is unlikely to be due to the mis-segregation of the fourth chromosome (because it is not essential for cells to survive; Gelbart, 1974), but may be caused by differences in the segregation of organelles between the sibling cells. For example, the smaller gonialblasts inherit more mitochondria, but less Golgi, than the gonialblasts in normal testes.
The observations reported by Chen et al. agree with recent reports from teams led by Iain Cheeseman (Kiyomitsu and Cheeseman, 2013) and Patrick Meraldi (Tan et al., 2015). They showed that changes in spindle position or the location of the metaphase plate (where chromosomes line up before the cell divides) can induce asymmetric division of animal cells that, under normal conditions, always produce equally sized siblings. Similar to the small gonialblasts in fruit fly testes, the smaller siblings died or spent longer preparing for cell division. There is currently no molecular explanation for how differences in sibling cell size could affect cell fate, but it is possible that altered segregation of cell organelles, a cell size checkpoint or cell competition may be responsible.
Whether animal cells produce sibling cells that are equal or unequal in size seems to be tightly controlled during development. In contrast to germline stem cells, neural stem cells in fruit flies develop asymmetric spindles so that, when they divide, the new neural stem cell is larger than its sibling (Homem and Knoblich, 2012; Figure 1C). If neural stem cells are forced to divide symmetrically they produce two new neural stem cells of equal size (Cabernard and Doe, 2009). Similarly, some neural stem cells in the worm Caenorhabditis elegans also produce siblings of different sizes (Ou et al., 2010). In both of these examples, the difference in cell size seems to be primarily controlled through asymmetric localization of a motor protein called non-muscle myosin, which drives cell division, and not through inherent asymmetries in the spindle (Ou et al., 2010; Cabernard et al., 2010; Connell et al., 2011). Thus, nature has developed at least two independent mechanisms to ensure that sibling cells adopt the right size.
It is currently not clear how Klp10A regulates the size of centrosomes, or what molecular mechanisms regulate spindle asymmetry in germline stem cells and other systems. In the future it may be possible to develop tools that allow us to artificially change the relative sizes of sibling cells in order to investigate how this affects animal development.
References
-
Asymmetric cortical extension shifts cleavage furrow position in Drosophila neuroblastsMolecular Biology of the Cell 22:4220–4226.https://doi.org/10.1091/mbc.E11-02-0173
-
A new mutant controlling mitotic chromosome disjunction in Drosophila melanogasterGenetics 76:51–63.
-
Drosophila neuroblasts: a model for stem cell biologyDevelopment 139:4297–4310.https://doi.org/10.1242/dev.080515
-
Control of asymmetric cell divisionCurrent Opinion in Cell Biology 31:84–91.https://doi.org/10.1016/j.ceb.2014.09.005
Article and author information
Author details
Publication history
Copyright
© 2017, Cabernard
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 1,648
- views
-
- 187
- downloads
-
- 3
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Genetics and Genomics
- Stem Cells and Regenerative Medicine
Retinal degeneration in mammals causes permanent loss of vision, due to an inability to regenerate naturally. Some non-mammalian vertebrates show robust regeneration, via Muller glia (MG). We have recently made significant progress in stimulating adult mouse MG to regenerate functional neurons by transgenic expression of the proneural transcription factor Ascl1. While these results showed that MG can serve as an endogenous source of neuronal replacement, the efficacy of this process is limited. With the goal of improving this in mammals, we designed a small molecule screen using sci-Plex, a method to multiplex up to thousands of single-nucleus RNA-seq conditions into a single experiment. We used this technology to screen a library of 92 compounds, identified, and validated two that promote neurogenesis in vivo. Our results demonstrate that high-throughput single-cell molecular profiling can substantially improve the discovery process for molecules and pathways that can stimulate neural regeneration and further demonstrate the potential for this approach to restore vision in patients with retinal disease.
-
- Stem Cells and Regenerative Medicine
Adult mammals, unlike some lower organisms, lack the ability to regenerate damaged hearts through cardiomyocytes (CMs) dedifferentiation into cells with regenerative capacity. Developing conditions to induce such naturally unavailable cells with potential to proliferate and differentiate into CMs, that is, regenerative cardiac cells (RCCs), in mammals will provide new insights and tools for heart regeneration research. In this study, we demonstrate that a two-compound combination, CHIR99021 and A-485 (2C), effectively induces RCCs from human embryonic stem cell-derived TNNT2+ CMs in vitro, as evidenced by lineage tracing experiments. Functional analysis shows that these RCCs express a broad spectrum of cardiogenesis genes and have the potential to differentiate into functional CMs, endothelial cells, and smooth muscle cells. Importantly, similar results were observed in neonatal rat CMs both in vitro and in vivo. Remarkably, administering 2C in adult mouse hearts significantly enhances survival and improves heart function post-myocardial infarction. Mechanistically, CHIR99021 is crucial for the transcriptional and epigenetic activation of genes essential for RCC development, while A-485 primarily suppresses H3K27Ac and particularly H3K9Ac in CMs. Their synergistic effect enhances these modifications on RCC genes, facilitating the transition from CMs to RCCs. Therefore, our findings demonstrate the feasibility and reveal the mechanisms of pharmacological induction of RCCs from endogenous CMs, which could offer a promising regenerative strategy to repair injured hearts.